Obstructive sleep apnea: a risk factor for work disability
- PMID: 19544756
- PMCID: PMC2690567
- DOI: 10.1093/sleep/32.6.791
Obstructive sleep apnea: a risk factor for work disability
Abstract
Study objective: To examine obstructive sleep apnea (OSA) as a risk factor for work disability.
Patients and setting: Consecutive patients referred to the University of California San Francisco Sleep Disorders Center with suspected OSA (n = 183).
Design: All patients underwent overnight polysomnography after completing a written survey which assessed work disability due to sleep problems, occupational characteristics and excessive daytime sleepiness (EDS) defined as an Epworth Sleepiness Scale score > 10.
Results: Among 150 currently employed patients, 83 had OSA on polysomnography (apnea-hypopnea index > or = 5). Compared with patients in whom both OSA and EDS were absent, patients with the combination of OSA and EDS were at higher risk of both recent work disability (adjusted odds ratio [OR], 13.7; 95% confidence interval [CI], 3.9-48) and longer-term work duty modification (OR, 3.6; CI, 1.1-12). When either OSA or EDS were absent, the strength of the association with work disability was less than when both OSA and EDS were present. When OSA was examined without respect to EDS, patients with OSA were at increased risk of recent work disability relative to patients without OSA (OR 2.6; 95% CI 1.2-5.8), but the association of OSA with longer-term work duty modification did not meet standard criteria for statistical significance (OR = 2.0, 95% CI 0.8-5.0).
Conclusions: The combination of OSA and EDS contributes to work disability, and OSA by itself contributes to recent work disability. These findings should highlight to employers and clinicians the importance of OSA in the workplace to encourage patients to be screened for OSA, particularly in situations of decreased productivity associated with EDS.
Similar articles
-
Uncovering the sleep disorders among young doctors.Sleep Breath. 2016 Dec;20(4):1137-1144. doi: 10.1007/s11325-016-1380-6. Epub 2016 Aug 17. Sleep Breath. 2016. PMID: 27535070
-
Forced expiratory volume in one second: A novel predictor of work disability in subjects with suspected obstructive sleep apnea.PLoS One. 2018 Jul 19;13(7):e0201045. doi: 10.1371/journal.pone.0201045. eCollection 2018. PLoS One. 2018. PMID: 30024962 Free PMC article.
-
Excessive daytime sleepiness, metabolic syndrome, and obstructive sleep apnea: two independent large cross-sectional studies and one interventional study.Respir Res. 2019 Dec 4;20(1):276. doi: 10.1186/s12931-019-1248-y. Respir Res. 2019. PMID: 31801522 Free PMC article.
-
The role of home sleep testing for evaluation of patients with excessive daytime sleepiness: focus on obstructive sleep apnea and narcolepsy.Sleep Med. 2019 Apr;56:80-89. doi: 10.1016/j.sleep.2019.01.014. Epub 2019 Jan 28. Sleep Med. 2019. PMID: 30803831 Review.
-
Excessive daytime sleepiness in obstructive sleep apnea: implications for driving licenses.Sleep Breath. 2020 Mar;24(1):37-47. doi: 10.1007/s11325-019-01903-6. Epub 2019 Jul 24. Sleep Breath. 2020. PMID: 31342234 Review.
Cited by
-
Testing a Consumer Wearables Program to Promote the Use of Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea: Protocol for a Pilot Randomized Controlled Trial.JMIR Res Protoc. 2024 Sep 19;13:e60769. doi: 10.2196/60769. JMIR Res Protoc. 2024. PMID: 39207912 Free PMC article.
-
Association between obstructive sleep apnea risk and type 2 diabetes among Emirati adults: results from the UAE healthy future study.Front Endocrinol (Lausanne). 2024 Jul 16;15:1395886. doi: 10.3389/fendo.2024.1395886. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39081790 Free PMC article.
-
Community-dwelling adults with functional limitations are at greater risk for sleep disturbances.Sleep Health. 2022 Apr;8(2):140-145. doi: 10.1016/j.sleh.2022.01.002. Epub 2022 Feb 25. Sleep Health. 2022. PMID: 35221260 Free PMC article.
-
Transition from APAP to CPAP may be a cost-effective health intervention in OSA patients.J Bras Pneumol. 2021 Dec 15;47(6):e20210286. doi: 10.36416/1806-3756/e20210286. eCollection 2021. J Bras Pneumol. 2021. PMID: 34932723 Free PMC article.
-
Long-term effects of solriamfetol on quality of life and work productivity in participants with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea.J Clin Sleep Med. 2021 Oct 1;17(10):1995-2007. doi: 10.5664/jcsm.9384. J Clin Sleep Med. 2021. PMID: 34606437 Free PMC article.
References
-
- Engleman H, Joffe D. Neuropsychological function in obstructive sleep apnoea. Sleep Med Rev. 1999;3:59–78. - PubMed
-
- Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002;165:1217–39. - PubMed
-
- Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet. 1994;343:572–5. - PubMed
-
- Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA. 2004;291:2013–6. - PubMed
-
- Hillman DR, Murphy AS, Pezzullo L. The economic cost of sleep disorders. Sleep. 2006;29:299–305. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
